Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

North West Fund for Biomedical

BioCentury | Feb 4, 2013
Emerging Company Profile

Incanthera: Using, not targeting, MMP

Incanthera using matrix metalloproteinase to activate prodrugs against cancer
BioCentury | Jun 18, 2012
Financial News

Alchemy Healthcare completes venture financing

BioCentury | Jan 23, 2012
Financial News

Incanthera completes venture financing

BioCentury | Jan 20, 2012
Financial News

Incanthera debuts

BioCentury | Jan 9, 2012
Financial News

Ai2 completes venture financing

BioCentury | Nov 21, 2011
Financial News

Onco-NX completes venture financing

BioCentury | Sep 19, 2011
Financial News

Evgen completes venture financing

BioCentury | Aug 8, 2011
Financial News

Alchemy Healthcare completes venture financing

BioCentury | Jun 13, 2011
Finance

Banker, Analyst, Venture Tracks

Biotech investor, banker, analyst personnel changes
Items per page:
1 - 9 of 9